EP3581654
AÐFERÐIR OG EFNASAMSETNINGAR TIL SÉRTÆKRAR HÖMLUNAR GLÝKÓLATOXÍÐASA (HAO1) MEÐ TVEGGJA ÞÁTTA RNA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.12.2014EP published:
31.3.2021EP application number:
19182616.3
EP translation filed:
21.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
25.12.2034Expiry date:
25.12.2026Next due date:
31.12.2026
Title:
METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GLYCOLATE OXIDASE (HAO1) BY DOUBLE-STRANDED RNA
Timeline
Today
26.12.2014EP application
31.3.2021EP Publication
21.4.2021Translation submitted
15.5.2021Registration published
25.12.2026Expires
Owner
Name:
Novo Nordisk A/SAddress:
Novo Alle 1, 2880 Bagsværd, DK
Inventor
Name:
BROWN, Bob, D.Address:
Littleton, MA 01460, US
Name:
DUDEK, Henryk, T.Address:
Wellesley, MA 02482, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361921181 PDate:
27.12.2013Country:
US
Number:
201461937838 PDate:
10.2.2014Country:
US
Supplementary protection
SPC number:
SPC345
Classification
Categories:
C12N 15/113, A61K 31/7088, C12N 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 1.12.2021
Expires: 25.12.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 15.1.2023
Expires: 25.12.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.12.2023
Expires: 25.12.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.11.2024
Expires: 25.12.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 19.12.2025
Expires: 25.12.2026
Payer: Árnason Faktor ehf.